SUMMARY Three monoclonal antibodies to neurofilaments (RT97, BFIO and 147), two of which also recognised neurofibrillary tangles (RT97 and BF10), have all been shown to be specific for phosphorylated epitopes. Treatment of histological sections with alkaline phosphatase prior to immunostaining resulted in reduction of axonal neurofilament staining with all three whilst the neurofibrillary tangles staining with BFIO was unaffected. Antibody 147 was found to recognise weakly some neurofibrillary tangles following alkaline phosphatase treatment. The results presented confirm the presence of structurally abnormal but phosphorylated neurofilaments in neurofibrillary tangles.
Neurofibrillary tangles are a pathological hallmark of senile dementia of the Alzheimer type (SDAT). Neurofibrillary tangles present in the perikaryon of affected neurons comprise bundles of 8-13 nm filaments helically twisted about each other in pairs with a cross-over roughly every 80 nm (paired helical filaments' -3). A correlation between the number of neurofibrillary tangles, the extent of choline acetyltransferase loss and the severity of dementia has been observed.4
The physical properties of paired helical filaments are somewhat unusual in that many are highly insoluble' but contain some extractable proteins with molecular weights in the range 57000 to 62000.6 Immunochemical studies indicate that neurofibrillary tangles may contain microtubule-associated antigens,7-12 vimentin antigens'3 and neurofilament antigens.'423 Using paired helical filaments as immunogen, three groups have found that polyclonal and monoclonal antibodies recognising the insoluble paired helical filaments either fail to detect crossreactive material in normal brain or indicate that normal brain contains very small amounts of such antigens, the nature of which remain to be determined. These anti-paired helical filaments antibodies do not react with any characterised cytoskeletal elements. '' 24-26 Previously we have described the specificities of several monoclonal antibodies (Mabs) to neurofilaments which were produced using two different immunogens, either Triton X-100-insoluble rat brain protein (Mabs RT97 and 147) or a crude soluble protein fraction from two pooled hippocampi from SDAT cases (Mab BFIO; 14) . RT97 and 147 react with the 210000 (210K)molwt and BFIO with the 155000 (155K) mol wt polypeptides of human neurofilaments. Two of these Mabs, RT97 and BFIO also react with neurofibrillary tangles in paraffin sections of brain from SDAT cases. 147 and some other anti-neurofilament Mabs produced by us do not react with neurofibrillary tangles.'4 The lack of neurofibrillary tangles staining by some antisera to neurofilaments has been noted before.8 18 27 -29 Sternberger and Sternberger30 have reported that treatment of sections from brain with alkaline phosphatase can alter the staining pattern obtained with different neurofilament monoclonal antibodies, depending on whether they recognised phosphorylated epitopes or not. We now show that Mabs RT97, BFIO and 147 are all specific for phosphorylated neurofilament epitopes but that staining of neurofilaments and neurofibrillary tangles are differentially affected by alkaline phosphatase indicating further that the neurofilamentous contribution to neurofibrillary tangles is from structurally abnormal but phosphorylated neurofilaments. (12 5 pg/ml).
After a brief wash the strips were incubated with the primary antibody (diluted in 3% (w/v) haemoglobin in TBS-azide) for one hour at room temperature followed by '25'-labelled rabbit anti-mouse immunoglobulins. The autoradiographs were produced by exposure to x-ray film (Fuji, England) of the washed and dried strips.
Immunocytochemical studies ofSDA T brain sections Paraffin wax sections were dewaxed and rehydrated just prior to use. Both the frozen sections and the paraffin wax sections were pretreated with hydrogen peroxide (0 3% v/v) in methanol before enzyme treatment. Alkaline phosphatase treatment (100 ig/ml alkaline phosphatase in 0 1 M TrisHaugh, Probst, Ulrich, Kahn, Anderton HCI pH 8 0) was carried out at 37°C for 2 5 h or longer as indicated. Also alkaline phosphatase was applied to some sections in 0 1 M sodium phosphate at the same concentration, or the sections were incubated with buffer only. After incubation with enzyme or buffer the samples were incubated with 20% (v/v) horse serum (Gibco) in TBS-azide for 30mins followed by primary antibody (diluted as indicated in 1% (v/v) horse serum in TBS-azide) overnight at 37°C. The samples were then stained using the Vectastain procedure except that incubations were carried out for I h and washing was done for 30 min (2 x 15 mins). The sections were counterstained with haemotoxylin followed by dehydration and mounting.
Immunocytochemical studies oJ isolated neurofibrillarY tangle preparations Neurofibrillary tangles were isolated essentially as described by Rasool et al22 using the SDS extraction procedure (SDS-NFT). The final homogenates were air-dried (2 p1 aliquots) onto teflon-coated multispot microscope slides (CA Hendley, Essex, England) and stored at 4°C. The samples were either incubated with enzyme in buffer as indicated or in buffer only. Trypsin treatment (40 pg/ml trypsin in 0-05 M Tris-HCl, pH 7 6, 0 3 M sodium chloride and 0 02 M calcium chloride) was carried out at 37°C for 1O mins. Immunocytochemistry was carried out as described above except the samples were not counterstained with haemotoxylin. Alzheimer neurofibrillary tangles contain phosphorylated and hidden neurofilament epitopes (fig 3c) . Treatment of the sections with alkaline phosphatase in 0 I M sodium phosphate buffer, pH 8-0 in place of Tris buffer, resulted in no change in subsequent staining patterns by the Mabs compared with sections treated with buffer alone (phosphate inhibits alkaline phosphatase). To confirm that the observed effects were due to the action of alkaline phosphatase and not due to a contaminating enzymatic activity, some experiments were repeated using a sample of highly purified alkaline phosphatase. Similar results were obtained. Discussion RT97, BFIO and 147 are directed against phosphorylated epitopes Alkaline phosphatase treatment of Western blots demonstrated unequivocally that the three Mabs used in this study, RT97, BFIO and 147, are all directed against phosphorylated epitopes present on one or other of the two larger neurofilament polypeptides (fig 1) . Binding to neurofilament proteins by a polyclonal antiserum was unaffected by alkaline phosphatase, but since we do not know if all phosphate groups were removed by the enzymatic treatment, it is not possible to conclude that this antiserum contains antibodies recognising only non-phosphorylated epitopes.
Staining ofaxonal neurofilaments is affected by alkaline phosphatase The immunocytochemical results also show that staining of axonal neurofilaments by these three Mabs is susceptible to alkaline phosphatase treatment. All three Mabs are similar to the group (ii) antibodies defined by Sternberger and Sternberger,30 since they recognise phosphorylated determinants and have similar staining patterns on fixed histological sections. However, the staining by our Mabs, on histological sections, is affected by alkaline phosphatase treatment, whereas two of the Sternberger's group (ii) Mabs are unaffected by any treatment (either alkaline phosphatase, trypsin or a combination) and the other three are unaffected by alkaline phosphatase treatment alone. However, a reduction in staining with their three group (ii) Mabs was found when the sections were treated with trypsin prior to alkaline phosphatase treatment.
In this study both unfixed and fixed sections from the same SDAT brain were used in order to establish if the fixation process had any effect on results obtained. It was found that the results obtained in both types of section were similar for each antibody, although the degree of effect may have varied (table 2) .
From immunocytochemical results it would seem that the RT97, BFIO Haugh, Probst, Ulrich, Kahn, Anderton SDS-NFT possibly represent a subpopulation in which this neurofilament epitope has been incorporated into or become associated with the insoluble PHF matrix. We have now found that treatment of SDS-NFT with trypsin results in staining of significantly more SDS-NFT by Mab RT97. This result suggests that neurofilaments may be a component of the insoluble paired helical filaments-core but that they are structurally altered or masked in the majority of SDS-NFT. The observation of Rasool and Selkoe23 that prolonged incubation of SDS-NFT (3 weeks) at room temperature in aqueous SDScontaining media results in greater numbers staining with Mab RT97 may be due to hydrolytic events. Johnson2' has also reported that Mab, T4, which stains neurofibrillary tangles and axonal neurofilaments will still stain neurofibrillary tangles in sections of SDAT brain following treatments designed to extract the normal axonal neurofilaments. Further effort is therefore now required in an attempt to break up the insoluble paired helical filaments to test if other cytoskeletal epitopes can be revealed. Possibly "inherent" paired helical filaments antigens are generated by gross modification of cytoskeletal proteins to the extent that anti-paired helical filaments antibodies fail to react with the normal proteins. 26 Certainly our findings that neurofibrillary tangles in situ can be stained after alkaline phosphatase treatment, by a neurofilament antibody hitherto believed to be unreactive towards neurofibrillary tangles (Mab 147) and that SDS-NFT can be stained in greater numbers by RT97 after trypsin treatment further supports the idea that neurofibrillary tangles in situ are composed, at least in part, of abnormal neurofilaments and that this may also extend to insoluble paired helical filaments. Trypsin treatment of sections is a technique which is often used in immunochemical studies and it is thought that this procedure does not cause false positives. In this particular case the possibility of neurofilament fragments becoming associated with neurofibrillary tangles following trypsin treatment is ruled out since normal neurofilaments have been removed from the preparation by prior solubilisation in SDS. Thus the physical state of the abnormal neurofilaments in neurofibrillary tangles is heterogeneous, a proportion being readily extractable and some remaining SDS-insoluble.
Future work should include a study ofneurofilament phosphoprotein metabolism Sternberger and Sternberger suggest that neurofilaments located in neuronal perikarya are not phosphorylated but are filamentous. Phosphorylation of these filaments may provide a further ordering of structure.30 The epitopes recognised by RT97 and 
